Valuation: GENFIT

Market Cap 720M 840M 673M 617M 1.16B 80.27B 1.18B 7.94B 3.11B 40.26B 3.15B 3.08B 133B P/E 2026 *
37.2x
P/E 2027 * 95.6x
Enterprise Value 669M 780M 625M 573M 1.08B 74.57B 1.1B 7.37B 2.89B 37.4B 2.93B 2.87B 124B EV / Sales 2026 *
6.68x
EV / Sales 2027 * 5.27x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-2.08%
1 week+5.54%
Current month-3.82%
1 month+3.98%
3 months+64.53%
6 months+78.93%
Current year+167.81%
1 week 12.96
Extreme 12.96
14.82
1 month 12.74
Extreme 12.74
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/7/23 Buy

Director

5,300 0.0106%
7/7/23 Buy

Chief Executive Officer

10,000 0.0201%
7/7/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%+5.54%+278.22%+335.19% 840M
+1.29%+2.37%+2.48%+24.79% 50.5B
-1.58%+4.88%+485.87%+609.24% 46.01B
-1.33%+4.34%+20.08%+89.40% 42.85B
+1.99%+5.80%+33.07%+19.21% 41.03B
-0.72%-3.91%+17.87%+47.98% 32.02B
+1.30%+5.88%+32.31%+150.50% 16.98B
-0.60%+5.10% - - 17.05B
+2.35%+3.17%+5.09%+34.52% 14.3B
+1.19%+3.78%+82.92%+45.29% 13.84B
Average +0.20%+2.78%+106.43%+150.68% 27.54B
Weighted average by Cap. +0.22%+2.40%+105.55%+152.47%

Financials

2026 *2027 *
Net sales 100M 117M 93.56M 85.84M 161M 11.16B 164M 1.1B 432M 5.6B 439M 429M 18.51B 124M 145M 116M 106M 200M 13.82B 203M 1.37B 535M 6.93B 543M 531M 22.92B
Net income 22.88M 26.67M 21.36M 19.6M 36.86M 2.55B 37.46M 252M 98.71M 1.28B 100M 97.96M 4.23B 6.8M 7.93M 6.35M 5.83M 10.96M 758M 11.14M 74.92M 29.34M 380M 29.77M 29.12M 1.26B
Net Debt -51.12M -59.59M -47.73M -43.79M -82.35M -5.7B -83.71M -563M -221M -2.86B -224M -219M -9.45B -66.17M -77.14M -61.79M -56.69M -107M -7.37B -108M -729M -286M -3.7B -290M -283M -12.23B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
21/08/26 EUR 14.06 -2.36% 254,150
19/08/26 EUR 14.40 +4.96% 410,201
18/08/26 EUR 13.72 -1.15% 203,967
17/08/26 EUR 13.88 +6.61% 404,952
14/08/26 EUR 13.02 -2.54% 137,537
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.40EUR
Average target price
15.90EUR
Spread / Average Target
+10.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock